Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 18 | ALLO | Allogene Therapeutics,… | MEXER | 47,700 | — | — | +13.6% | Open the original filing on SEC.gov |
| Dec 18, 2025 | ALLO | Allogene Therapeutics,… | MEXER◆ | 47,700 | — | — | — | Open the original filing on SEC.gov |
| Dec 18, 2025 | ALLO | Allogene Therapeutics,… | MEXER | 47,700 | — | — | +15.7% | Open the original filing on SEC.gov |
| Jun 20, 2025 | KRON | Kronos Bio, Inc. | DTOISS◆ | 34,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | KRON | Kronos Bio, Inc. | DTOISS◆ | 34,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | KRON | Kronos Bio, Inc. | DTOISS◆ | 34,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | KRON | Kronos Bio, Inc. | DTOISS◆ | 20,600 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | KRON | Kronos Bio, Inc. | UTENDR | 94,481 | $0.57 | $53.9K | -100.0% | Open the original filing on SEC.gov |
| Jun 18, 2025 | ALLO | Allogene Therapeutics,… | AGRANT◆ | 94,500 | — | — | — | Open the original filing on SEC.gov |